Human herpesvirus-8 glycoprotein B interacts with Epstein-Barr virus (EBV) glycoprotein 110 but fails to complement the infectivity of EBV mutants

Virology

Volumn 251, Issue 2, 1998, Pages 402-413

  Pertel, Peter E ^a   Spear, Patricia G ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ARTICLE; CELL NUCLEUS MEMBRANE; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; EXPRESSION VECTOR; GLYCOSYLATION; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE; LYMPHOBLASTOID CELL LINE; MOLECULAR CLONING; NONHUMAN; OLIGOMERIZATION; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; VIRUS DETECTION; VIRUS INFECTIVITY;

EID: 0032567118     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9412     Document Type: Article

References (85)

1. Agius C. T., Crabb B. S., Telford E. A. R., Davison A. J., Studdert M. J. Comparative studies of the structural proteins and glycoproteins of equine herpesviruses 2 and 5. J. Gen. Virol. 75:1994;2707-2717.
2. Ambroziak J. A., Blackbourn D. J., Herndier B. G., Glogau R. G., Gullett J. H., McDonald A. R., Lennette E. T., Levy J. A. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science. 268:1995;582-583.
3. Argos P., Rao J. K. N., Hargrave P. A. Structural prediction of membrane bound proteins. Eur. J. Biochem. 128:1982;565-575.
4. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C., Tuffnell P. S., Barrell B. G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:1984;207-211.
5. Bause E. Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes. Biochem. J. 209:1983;331-336.
6. Boyle K., Compton T. Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J. Virol. 72:1998;1826-1833.
7. Britt W. J. Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology. 135:1984;369-378.
8. Britt W. J., Vugler L. G. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J. Virol. 63:1989;403-410.
9. Brücher K. H., Garten W., Klenk H. D., Shaw E., Radsak K. Inhibition of endoproteolytic cleavage of cytomegalovirus (HCMV) glycoprotein B by palmitoyl-peptidyl-chloromethyl ketone. Virology. 178:1990;617-620.
10. Bzik D. J., Fox B. A., DeLuca N. A., Person S. Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology. 133:1984;301-314.
11. Cai W., Gu B., Person S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62:1988;2596-2604.
12. Cai W., Person S., Warner S. C., Zhou J., DeLuca N. A. Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1. J. Virol. 61:1987;714-721.
13. Claesson-Welsh L., Spear P. G. Oligomerization of herpes simplex virus glycoprotein B. J. Virol. 60:1986;803-806.
14. Compton T., Nowlin D. M., Cooper N. R. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology. 193:1993;834-841.
15. Cooper N. R. Early events in human herpesvirus infection of cells. Cellular Receptors for Animal Viruses. 1994;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 365-388.
16. Emini E. A., Luka J., Armstrong M. E., Keller P. M., Ellis R. W., Pearson G. R. Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B. Virology. 157:1987;552-555.
17. Gavel Y., von Heijne G. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: Implications for protein engineering. Protein Eng. 3:1990;433-442.
18. Goltz M., Broll H., Mankertz A., Weigelt W., Ludwig H., Buhk H.-J., Borchers K. Glycoprotein B of bovine herpesvirus 4: Its phylogenetic relationship to gB equivalents of the herpesviruses. Virus Genes. 9:1994;53-59.
19. Gong M., Kieff E. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110. J. Virol. 64:1990;1507-1516.
20. Gong M., Ooka T., Matsuo T., Kieff E. Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. J. Virol. 61:1987;499-508.
21. Gretch D. R., Kari B., Rasmussen L., Gehrz R. C., Stinski M. F. Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus. J. Virol. 62:1988;875-881.
22. Grose C., Edwards D. P., Weigle K. A., Friedrichs W. E., McGuire W. L. Varicella-zoster virus-specific gp140: A highly immunogenic and disulfide-linked structural glycoprotein. Virology. 132:1984;138-146.
23. Haddad R. S., Hutt-Fletcher L. M. Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J. Virol. 63:1989;4998-5005.
24. Haffey M. L., Spear P. G. Alterations in glycoprotein gB specified by mutants and their partial revertants in herpes simplex virus type 1 and relationship to other mutant phenotypes. J. Virol. 35:1980;114-128.
25. Heineman T., Gong M., Sample J., Kieff E. Identification of the Epstein-Barr virus gp85 gene. J. Virol. 62:1988;1101-1107.
26. Herold B. C., Visalli R. J., Susmarski N., Brandt C. R., Spear P. G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 75:1994;1211-1222.
27. Herold B. C., WuDunn D., Soltys N., Spear P. G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1991;1090-1098.
28. Herrold R. E., Marchini A., Fruehling S., Longnecker R. Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo. J. Virol. 70:1996;2049-2054.
29. Highlander S. L., Goins W. F., Person S., Holland T. C., Levine M., Glorioso J. C. Oligomer formation of the gB glycoprotein of herpes simplex virus type 1. J. Virol. 65:1991;4275-4283.
30. Huber M. T., Compton T. Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex. J. Virol. 71:1997;5391-5398.
31. Hutt-Fletcher L. M. Epstein-Barr virus glycoproteins-Beyond gp350/220. Epstein-Barr Virus Rep. 2:1995;49-53.
32. Johnson D. C., Spear P. G. Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J. Virol. 43:1982;1102-1112.
33. Kari B., Gehrz R. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J. Virol. 66:1992;1761-1764.
34. Kopp A., Blewett E., Misra V., Mettenleiter T. C. Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus. J. Virol. 68:1994;1667-1674.
35. Kopp A., Mettenleiter T. C. Stable rescue of a glycoprotein gII deletion mutant of pseudorabies virus by glycoprotein gI of bovine herpesvirus 1. J. Virol. 66:1992;2754-2762.
36. Laquerre S., Person S., Glorioso J. C. Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain. J. Virol. 70:1996;1640-1650.
37. Lee S. K., Compton T., Longnecker R. Failure to complement infectivity of EBV and HSV-1 glycoprotein B (gB) deletion mutants with gBs from different human herpesvirus subfamilies. Virology. 237:1997;170-181.
38. Lee S. K., Longnecker R. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication. J. Virol. 71:1997;4092-4097.
39. Li L., Nelson J. A., Britt W. J. Glycoprotein H-related complexes of human cytomegalovirus: Identification of a third protein in the gCIII complex. J. Virol. 71:1997;3090-3097.
40. Li Q., Turk S. M., Hutt-Fletcher L. M. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol. 69:1995;3987-3994.
41. Lomonte P., Filee P., Lyaku J. R., Bublot M., Pastoret P.-P., Thiry E. Glycoprotein B of bovine herpesvirus 4 is a major component of the virion, unlike that of two other gammaherpesviruses, Epstein-Barr virus and murine gammaherpesvirus 68. J. Virol. 71:1997;3332-3335.
42. Lukacs N., Thiel H.-J., Mettenleiter T. C., Rziha H.-J. Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex. J. Virol. 53:1985;166-173.
43. Manservigi R., Spear P. G., Buchan A. Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins. Proc. Natl. Acad. Sci. USA. 74:1977;3913-3917.
44. Marshall R. Glycoproteins. Annu. Rev. Biochem. 41:1972;673-702.
45. Mettenleiter T. C., Spear P. G. Glycoprotein gB (gII) of pseudorabies virus can functionally substitute for glycoprotein gB in herpes simplex virus type 1. J. Virol. 68:1994;500-504.
46. Miethke A., Keil G. M., Weiland F., Mettenleiter T. C. Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. J. Gen. Virol. 76:1995;1623-1635.
47. Miller N., Hutt-Fletcher L. M. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus. J. Virol. 62:1988;2366-2372.
48. Miller N., Hutt-Fletcher L. M. Epstein-Barr virus enters B cells and epithelial cells by different routes. J. Virol. 66:1992;3409-3414.
49. Misra V., Blewett E. L. Construction of herpes simplex viruses that are pseudodiploid for the glycoprotein B gene: A strategy for studying the function of an essential herpesvirus gene. J. Gen. Virol. 72:1991;385-392.
50. Montalvo E. A., Grose C. Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140). J. Virol. 61:1987;2877-2884.
51. Moore P. S., Gao S.-J., Dominguez G., Cesarman E., Lungu O., Kowles D. M., Garber R., Pellett P. E., McGeoch D. J., Chang Y. Primary characterization of a herpesvirus agent associated with Kaposi,s sarcoma. J. Virol. 70:1996;549-558.
52. Navarro D., Paz P., Tugizov S., Topp K., La Vail J., Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology. 197:1993a;143-158.
53. Navarro D., Qadri I., Pereira L. Transport and secretion of truncated derivatives of herpes simplex virus 1 glycoprotein B. Virology. 192:1993b;234-245.
54. Nemerow G. R., Cooper N. R. Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process. Virology. 132:1984;186-198.
55. Nemerow G. R., Houghten R. A., Moore M. D., Cooper N. R. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell. 56:1989;369-377.
56. Nemerow G. R., Mold C., Schwend V. K., Tollefson V., Cooper N. R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d. J. Virol. 61:1987;1416-1420.
57. Novotny, M. J. 1996, Northwestern University, Evanston, IL.
58. Para M. F., Parish M. L., Noble A. G., Spear P. G. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. J. Virol. 55:1985;483-488.
59. Pellett P. E., Biggin M. D., Barrell B., Roizman B. Epstein-Barr virus genome may encode a protein showing significant amino acid and predicted secondary structure homology with glycoprotein B of herpes simplex virus 1. J. Virol. 56:1985a;807-813.
60. Pellett P. E., Kousoulas K. G., Pereira L., Roizman B. Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: Primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J. Virol. 53:1985b;243-253.
61. Pereira L. Function of glycoprotein B homologues of the familyherpesviridae. Infect Agents Dis. 3:1994;9-28.
62. Pereira L., Ali M., Kousoulas K., Huo B., Banks T. Domain structure of herpes simplex virus 1 glycoprotein B: Neutralizing epitopes map in regions of continuous and discontinuous residues. Virology. 172:1989;11-24.
63. Perlman D., Halvorson H. O. A putative signal peptidase recognition site and sequence in eucaryotic and procaryotic signal peptides. J. Mol. Biol. 167:1983;391-409.
64. Qadri I., Gimeno C., Navarro D., Pereira L. Mutations in conformation-dependent domains of herpes simplex virus 1 glycoprotein B affect the antigenic properties, dimerization, and transport of the molecule. Virology. 180:1991;135-152.
65. Qualtiere L. F., Pearson G. R. Epstein-Barr virus-induced membrane antigens: Immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Int. J. Cancer. 23:1979;808-817.
66. Rauh I., Mettenleiter T. C. Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J. Virol. 65:1991;5348-5356.
67. Rauh I., Weiland F., Fehler F., Keil G. M., Mettenleiter T. C. Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. J. Virol. 65:1991;621-631.
68. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Redes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med. 2:1996;342-346.
69. Rickinson A. B., Kieff E. Epstein-Barr virus. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;2397-2446 Lipincott-Raven, Philadelphia.
70. Ross L. J. N., Sanderson M., Scott S. D., Bins M. M., Doel T., Milne B. Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 70:1989;1789-1804.
71. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y., Moore P. S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
72. 2. J. Virol. 29:1979;1159-1167.
73. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology. 167:1988;207-225.
74. Spear P. G. Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells. J. Virol. 17:1976;991-1008.
75. Spear P. G. Entry of alphaherpesviruses into cells. Semin. Virol. 4:1993;167-180.
76. Stewart J. P., Janjua N. J., Sunil-Chandra N. P., Nash A. A., Arrand J. R. Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: Similarity to Epstein-Barr virus gB (gp110). J. Virol. 68:1994;6496-6504.
77. Swaminathan S., Tomkinson B., Kieff E. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicatesin vitro. Proc. Natl. Acad. Sci. USA. 88:1991;1546-1550.
78. Tanner J., Weis J., Fearon D., Whang Y., Kieff E. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell. 50:1987;203-213.
79. Tanner J., Whang Y., Sample J., Sears A., Kieff E. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J. Virol. 62:1988;4452-4464.
80. Teasdale R. D., Jackson M. R. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu. Rev. Cell Dev. Biol. 12:1996;27-54.
81. Vey M., Schafer W., Reis B., Ohuchi R., Britt W., Garten W., Klenk H. D., Radsak K. Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology. 206:1995;746-749.
82. von Heijne G. How signal sequences maintain sequence specificity. J. Mol. Biol. 173:1984;243-351.
83. Whealy M. E., Robbins A. K., Enquist L. W. The export pathway of the pseurabies virus gB homolog gII involves oligomer formation in the endoplasmic reticulum and protease processing in the golgi apparatus. J. Virol. 64:1990;1946-1955.
84. Yaswen L. R., Stephens E. B., Davenport L. C., Hutt-Fletcher L. M. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology. 195:1993;387-396.
85. Zheng Z., Maidji E., Tugizov S., Pereira L. Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding. J. Virol. 70:1996;8029-8040.